Search results

Fox Corporation FOXA reported fourth-quarter fiscal 2026 adjusted earnings of $1.79 per share, which beat the Zacks Consensus Estimate of $1.34 by 33.58% and increased 41% year over year from

Altria Group, Inc.’s MO smoke-free strategy is increasingly centered on nicotine pouches, with on! PLUS emerging as a key part of that effort. In the second quarter of 2026, Helix expanded on! PLUS

Tripadvisor TRIP shares have appreciated 3.5% since the company reported its second quarter 2026 results on Aug. 6. The move comes even as both revenues and earnings missed the Zacks Consensus

AMC Entertainment Holdings AMC delivered a standout second-quarter 2026 performance, with its European operations emerging as a key growth driver.

Attendance across Europe jumped 17.9% year over

Fiserv, Inc. FISV reset investor expectations after second-quarter 2026 earnings and revenues missed the Zacks Consensus Estimate and management lowered its full-year outlook. The central question

Marathon Petroleum Corporation MPC shares have gained 18.1% over the past three months, while the Zacks Consensus Estimate for current fiscal-year earnings has risen 41.6% in the past four weeks

Disney DIS delivered a third-quarter fiscal 2026 performance leaning on two durable engines, Experiences and streaming, even as shares have struggled to reflect that operating momentum. For the

Shares of Replimune Group REPL have surged nearly 223% over the past three months, as the company steadily advanced its lead oncolytic immunotherapy, RP1 (vusolimogene oderparepvec), toward

Market volatility is far from over, as investors continue to navigate shifting risks, ranging from bouts of rising geopolitical tensions stemming from the Middle East conflict to persistent weakness

Immunocore Holdings plc IMCR offers a clear trade-off between commercial momentum and valuation risk. Kimmtrak continues to expand in metastatic uveal melanoma, while late-stage studies could open

Immunocore Holdings plc IMCR posted second-quarter 2026 revenues of $115.9 million, up 18.3% year over year and above the Zacks Consensus Estimate of $114 million. The company’s loss of 2 cents per

Gates Industrial Corporation Ltd. GTES raised its 2026 outlook after second-quarter 2026 results showed improving demand across a broad range of industrial markets. Higher core sales, improved

Gates Industrial Corporation Ltd. GTES entered the second half of 2026 with better operating momentum. The company's second-quarter core sales rose 4.9% year over year, and adjusted EBITDA margin

EPAM Systems EPAM stock climbed close to 5% after announcing strong second-quarter 2026 results, with revenues and earnings surpassing the Zacks Consensus Estimate despite continued macroeconomic

Belden (BDC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of

Investors might want to bet on Lam Research (LRCX), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Investors might want to bet on Encore Capital Group (ECPG), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings

Korro Bio, Inc. (KRRO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth